These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7246128)

  • 21. [Transient lowering of the IgA level during Diphedan therapy].
    Balogh E; Máttyus A; Németh C; Szabadosné NM
    Orv Hetil; 1979 Sep; 120(36):2179-82. PubMed ID: 514604
    [No Abstract]   [Full Text] [Related]  

  • 22. IgG subclasses in epileptic patients treated with phenytoin.
    Gilhus NE; Lea T
    J Neurol; 1989 Mar; 236(3):149-52. PubMed ID: 2496207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
    Barth N; Alván G; Borgå O; Sjöqvist F
    Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenytoin influence on human lymphocyte mitogen response: a prospective study of epileptic and nonepileptic patients.
    Gabourel JD; Davies GH; Bardana EJ; Ratzlaff NA
    Epilepsia; 1982 Aug; 23(4):367-76. PubMed ID: 7094904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Saliva phenobarbital and phenytoin concentrations in epileptic adolescents.
    Friedman IM; Litt IF; Henson R; Holtzman D; Halverson D
    J Pediatr; 1981 Apr; 98(4):645-7. PubMed ID: 7205497
    [No Abstract]   [Full Text] [Related]  

  • 26. Ineffectiveness of folic acid supplementation against phenytoin-induced decrease in salivary immunoglobulin A concentration of epileptic patients.
    Zare M; Ghazvini MR; Yazdi HR; Nezhad VS; Chitsaz A
    Eur Neurol; 2008; 59(6):299-301. PubMed ID: 18408370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of plasma and saliva levels of carbamazepine and phenytoin as monotherapy.
    Callaghan N; Goggin T
    Ir J Med Sci; 1984 May; 153(5):170-3. PubMed ID: 6480316
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of antiepileptic drugs on serum and salivary IgA.
    Aarli JA; Tönder O
    Scand J Immunol; 1975; 4(4):391-6. PubMed ID: 1188324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenytoin-induced IgA depression.
    Ruff ME; Pincus LG; Sampson HA
    Am J Dis Child; 1987 Aug; 141(8):858-61. PubMed ID: 3631017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compliance with anticonvulsant therapy in a hospital clinic and in the community.
    Mucklow JC; Dollery CT
    Br J Clin Pharmacol; 1978 Jul; 6(1):75-9. PubMed ID: 666949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free phenytoin monitoring in serum and saliva of epileptic patients in China.
    Cai WM; Zhu GZ; Chen G
    Ther Drug Monit; 1993 Feb; 15(1):31-4. PubMed ID: 8451777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in the serum immunoglobulins levels induced by phenytoin in epileptic children].
    Talesnik E; Rivero S; González B
    Rev Chil Pediatr; 1985; 56(2):76-80. PubMed ID: 4089271
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation between serum and salivary phenytoin concentrations in Thai epileptic children.
    Liamsuwan S; Jaiweerawattana U
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S172-7. PubMed ID: 22043772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum IgA deficiency induced by prolonged phenytoin treatment.
    Talesnik E; Rivero SJ; González B
    Rev Invest Clin; 1989; 41(4):331-5. PubMed ID: 2631168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenytoin kinetics during pregnancy and the puerperium.
    Knott C; Williams CP; Reynolds F
    Br J Obstet Gynaecol; 1986 Oct; 93(10):1030-7. PubMed ID: 3790462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of phenytoin on immunoglobulin concentrations in nasal secretions.
    Gilhus NE; Aarli JA
    Acta Pathol Microbiol Scand C; 1981 Feb; 89(1):63-7. PubMed ID: 7293776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary anticonvulsant levels in children with epilepsy.
    Day RE; Chambers RE
    Br J Clin Pract; 1981 Jan; 35(1):25-9. PubMed ID: 7259942
    [No Abstract]   [Full Text] [Related]  

  • 38. Phenytoin therapy for epileptic children: evaluation of salivary and plasma concentrations and of methods of assessing compliance.
    Zysset T; Rüdeberg A; Vassella F; Küpfer A; Bircher J
    Dev Med Child Neurol; 1981 Feb; 23(1):66-75. PubMed ID: 6781961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring phenytoin therapy using citric acid-stimulated saliva in infants and children.
    Lifshitz M; Ben-Zvi Z; Gorodischer R
    Ther Drug Monit; 1990 Jul; 12(4):334-8. PubMed ID: 2396306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of diphenylhydantoin in serum and secretory IgA concentrations.
    Martínez-Cairo S; Guiscafre H; Alvarez MT; Muñóz-Hernández O
    Arch Invest Med (Mex); 1980; 11(1):1-8. PubMed ID: 6772121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.